Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    11069188 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Preoperative levosimendán and Hip Fracture
Conditions: Ventricular Dysfunction, Left;   Hip Fracture
Intervention: Drug: Levosimendan
2 Completed FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: MK0217, alendronate sodium / Duration of Treatment : 5 Years;   Drug: Comparator : placebo (unspecified) /Duration of Treatment : 5 Years

Study has passed its completion date and status has not been verified in more than two years.